Toward an understanding of nonsyndromic craniosynostosis: Altered patterns of TGF-β receptor and FGF receptor expression induced by intrauterine head constraint

Annals of Plastic Surgery

Volumn 46, Issue 5, 2001, Pages 546-554

  Hunenko, Oksana ^a   Karmacharya, Jagajan ^a   Ong, Grace ^a   Kirschner, Richard E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; CERCLAGE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; FETUS GROWTH; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION;

EID: 0035043261     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200105000-00015     Document Type: Article

References (35)

1. Sagittal craniostenosis: Fetal head constraint as one possible cause
2. Metopic craniostenosis as a consequence of fetal head constraint: Two interesting experiments of nature
3. Coronal craniostenosis: Fetal head constraint as one possible cause
4. Intrauterine constraint and craniosynostosis
5. Sutures and intrauterine deformation
6. Craniosynostosis and altered patterns of fetal TGF-beta expression induced by intrauterine constraint
7. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion
8. TGF-beta 1, TGF-beta 2, TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro
9. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion
10. Mechanism of activation of the TGF-beta receptor
11. Specificity, diversity, and regulation in TGF-beta superfamily signaling
12. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion
13. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta 1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat
14. Immunolocalization of basic fibroblast growth factor and fibreblast growth factor receptor-1 and receptor-2 in rat cranial sutures
15. FGF-, BMP-, Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development
16. Craniosynostosis: Genes and mechanisms
17. Clinical spectrum of fibroblast growth factor receptor mutations
18. FGFR2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
19. An in vivo experimental model for prenatal craniosynostosis
20. Sutural biology and the correlates of craniosynostosis
21. Transforming growth factor-beta
22. Role of active and latent transforming growth factor beta in bone formation
23. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro
24. Multiple regulatory effects by transforming growth factor-beta on type I collagen levels in osteoblast-enriched cultures from fetal rat bone
25. Chemotactic response of osteoblast like cells to transforming growth factor β
26. TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1
27. In vivo stimulation of bone formation by transforming growth factor-beta
28. Transforming growth factor-beta gene family members and bone
29. Mechanical strain-induced proliferation of osteoblastic cells parallels increased TGF-beta 1 mRNA
30. Increased bone formation and decreased bone resorption in fetal mouse calvaria as a result of intermittent compressive force in vitro
31. Mechanical loading stimulates the release of transforming growth factor-beta activity by cultured mouse calvariae and periosteal cells
32. TGF-beta receptor signaling
33. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2
34. Betaglycan presents ligand to the TGF beta signaling receptor
35. Signal transduction by receptors with tyrosine kinase activity